273 related articles for article (PubMed ID: 8103066)
1. Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes.
Mehrotra PT; Wu D; Crim JA; Mostowski HS; Siegel JP
J Immunol; 1993 Sep; 151(5):2444-52. PubMed ID: 8103066
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of IL-7 and IL-12 on human T cell activation.
Mehrotra PT; Grant AJ; Siegel JP
J Immunol; 1995 May; 154(10):5093-102. PubMed ID: 7730615
[TBL] [Abstract][Full Text] [Related]
3. Synergy between interleukin 4 and interleukin 2 conveys resistance to cyclosporin A during primary in vitro activation of murine CD8 cytotoxic T cell precursors.
Bubeck R; Miethke T; Heeg K; Wagner H
Eur J Immunol; 1989 Apr; 19(4):625-30. PubMed ID: 2499483
[TBL] [Abstract][Full Text] [Related]
4. Lymphocytes infiltrating ovarian malignant ascites: modulation of IL-2-induced proliferation by IL-4 and of selective increase in CD8+ T cells by TNF-alpha.
Ioannides CG; Rashed S; Fisk B; Fan D; Itoh K; Freedman RS
Lymphokine Cytokine Res; 1991 Aug; 10(4):307-15. PubMed ID: 1932375
[TBL] [Abstract][Full Text] [Related]
5. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity.
Owen-Schaub LB; Gutterman JU; Grimm EA
Cancer Res; 1988 Feb; 48(4):788-92. PubMed ID: 3257408
[TBL] [Abstract][Full Text] [Related]
6. Cellular and molecular mechanisms of the IL-12-induced increase in allospecific murine cytolytic T cell activity. Implications for the age-related decline in CTL.
Bloom ET; Horvath JA
J Immunol; 1994 May; 152(9):4242-54. PubMed ID: 7908914
[TBL] [Abstract][Full Text] [Related]
7. IL-10: a novel cytotoxic T cell differentiation factor.
Chen WF; Zlotnik A
J Immunol; 1991 Jul; 147(2):528-34. PubMed ID: 1906502
[TBL] [Abstract][Full Text] [Related]
8. IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures.
Spits H; Yssel H; Paliard X; Kastelein R; Figdor C; de Vries JE
J Immunol; 1988 Jul; 141(1):29-36. PubMed ID: 2454260
[TBL] [Abstract][Full Text] [Related]
9. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12.
Okamoto I; Kohno K; Tanimoto T; Ikegami H; Kurimoto M
J Immunol; 1999 Mar; 162(6):3202-11. PubMed ID: 10092771
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous mechanisms of human cytotoxic T lymphocyte generation. II. Differential effects of IL-6 on the helper cell-independent generation of CTL from CD8+ precursor subpopulations.
Bass HZ; Yamashita N; Clement LT
J Immunol; 1993 Sep; 151(6):2895-903. PubMed ID: 8376760
[TBL] [Abstract][Full Text] [Related]
11. Distinct regulatory effects of IL-4 and TNF-alpha during CD3-dependent and CD3-independent initiation of human T-cell activation.
Damle NK; Doyle LV
Lymphokine Res; 1989; 8(2):85-97. PubMed ID: 2525210
[TBL] [Abstract][Full Text] [Related]
12. Synergistic and antagonistic effects of IL-1 alpha and IL-4, respectively, on the IL-2-dependent growth of a T cell receptor-gamma delta+ human T leukemia cell line.
Santoli D; O'Connor R; Cesano A; Phillips P; Colt TL; Lange B; Clark SC; Rovera G
J Immunol; 1990 Jun; 144(12):4703-11. PubMed ID: 2351825
[TBL] [Abstract][Full Text] [Related]
13. Regulation of human cytotoxic T lymphocyte development by IL-7.
Hickman CJ; Crim JA; Mostowski HS; Siegel JP
J Immunol; 1990 Oct; 145(8):2415-20. PubMed ID: 2145359
[TBL] [Abstract][Full Text] [Related]
14. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753
[TBL] [Abstract][Full Text] [Related]
15. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
[TBL] [Abstract][Full Text] [Related]
16. IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes.
Kawakami Y; Custer MC; Rosenberg SA; Lotze MT
J Immunol; 1989 May; 142(10):3452-61. PubMed ID: 2654291
[TBL] [Abstract][Full Text] [Related]
17. Generation of memory CD4+, CD8+, CD45RO+ and CD16- lymphocytes activated with IL-2, INF-gamma, and TNF-alpha with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture.
Rangel R; Rocha L; Ramirez JL; Ibarra MJ; Solorza G; Monroy A; Ramirez MA; Herrera A; Weiss-Steider B
Eur Cytokine Netw; 1995; 6(3):195-202. PubMed ID: 8589277
[TBL] [Abstract][Full Text] [Related]
18. IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells.
Smyth MJ; Ortaldo JR; Bere W; Yagita H; Okumura K; Young HA
J Immunol; 1990 Aug; 145(4):1159-66. PubMed ID: 2143209
[TBL] [Abstract][Full Text] [Related]
19. Promotion of human T lymphocyte proliferation by IL-4.
Mitchell LC; Davis LS; Lipsky PE
J Immunol; 1989 Mar; 142(5):1548-57. PubMed ID: 2783946
[TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12.
Cesano A; Visonneau S; Clark SC; Santoli D
J Immunol; 1993 Sep; 151(6):2943-57. PubMed ID: 8104216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
